Christina Ohnsman

Christina Ohnsman

Company: REGENXBIO

Job title: Senior Clinical Development Lead

Bio:

Christina Ohnsman, MD is Senior Clinical Development Lead of gene therapy for rare diseases at REGENXBIO Inc. Prior to this, she provided strategic guidance to Spark Therapeutics during the development and launch of Luxturna®. A pediatric ophthalmologist by background and founder of a medical communications and consulting firm, her passion is bringing gene therapies to people living with rare, previously untreatable diseases.

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.